Pharmacological treatment of renal cell carcinoma: A review
Betöltés ...
Dátum
Authors
Folyóirat címe
Folyóirat ISSN
Kötet címe (évfolyam száma)
Kiadó
DOI
Absztrakt
This thesis review discusses the pharmacological treatment of Renal Cell Carcinoma, which is the most fatal urological malignancy. Drugs such as Bevacizumab, Sorafenib, Cabozantinib, Sunitinib, Tivozanib, Pazopanib, Lenvatinib, Axitinib, Everolimus, Ipilimumab, Nivlomumab, Aldesleukin and Belzutifan are discussed including their mechanism of action, pharmacokinetics, safety and clinical trials in Renal Cell Carcinoma.
Leírás
Kulcsszavak
Bevacizumab , Sorafenib , Sunitinib , Tivozanib , Pazopanib , Lenvatinib , Axitinib , Everolimus , Ipilimumab , Nivolumab , Aldesleukin , Belzutifan